NCT02928432View on ClinicalTrials.gov

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

January 31, 2017

Conditions
Prostate Cancer
Interventions
DRUG

Steroids switch

Change of prednisone 5mg/12h to dexamethasone 0.5mg/24h

Trial Locations (1)

28029

Spanish National Cancer Research Centre (CNIO), Madrid

All Listed Sponsors
collaborator

Instituto de Investigacion Biomedica de Malaga

OTHER

collaborator

Fundación de investigación HM

OTHER

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

University of Salamanca

OTHER

lead

Centro Nacional de Investigaciones Oncologicas CARLOS III

OTHER

NCT02928432 - SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone | Biotech Hunter | Biotech Hunter